TY - JOUR
T1 - Development and validation of a risk assessment tool for gastric cancer in a general Japanese population
AU - Iida, Masahiro
AU - Ikeda, Fumie
AU - Hata, Jun
AU - Hirakawa, Yoichiro
AU - Ohara, Tomoyuki
AU - Mukai, Naoko
AU - Yoshida, Daigo
AU - Yonemoto, Koji
AU - Esaki, Motohiro
AU - Kitazono, Takanari
AU - Kiyohara, Yutaka
AU - Ninomiya, Toshiharu
N1 - Funding Information:
The authors thank the residents of the town of Hisayama for their participation in the survey and the staff of the Division of Health and Welfare of Hisayama for their cooperation with this study. We also would like to gratefully and sincerely thank Prof. Yoshinao Oda, Prof. Toru Iwaki, and colleagues from the Department of Anatomic Pathology and Department of Neuropathology, Graduate School of Medical Sciences, Kyushu University, who provided their insight and expertise regarding the autopsy findings that greatly assisted the research. The authors declare that they have no conflict of interest. This study was supported in part by Grants-in-Aid for Scientific Research (A) (16H02644, and 16H02692) and (B) (16H05850, 16H05557, and 17H04126) and (C) (15K09267, 15K08738, 15K09835, 16K09244, 17K09114, 17K09113, and 17K01853) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; by Health and Labour Sciences Research Grants of the Ministry of Health, Labour and Welfare of Japan (H25-Junkankitou [Seishuu]-Sitei-022, H29-Junkankitou-Ippan-003, and H27-Shokuhin-[Sitei]-017); and by the Japan Agency for Medical Research and Development (dk0207025, ek0210082, gm0610007, ek0210083, km0405202, ek0210080).
Funding Information:
Funding This study was supported in part by Grants-in-Aid for Scientific Research (A) (16H02644, and 16H02692) and (B) (16H05850, 16H05557, and 17H04126) and (C) (15K09267, 15K08738, 15K09835, 16K09244, 17K09114, 17K09113, and 17K01853) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; by Health and Labour Sciences Research Grants of the Ministry of Health, Labour and Welfare of Japan (H25-Junkankitou [Seishuu]-Sitei-022, H29-Junkankitou-Ippan-003, and H27-Shokuhin-[Sitei]-017); and by the Japan Agency for Medical Research and Development (dk0207025, ek0210082, gm0610007, ek0210083, km0405202, ek0210080).
Publisher Copyright:
© 2017, The International Gastric Cancer Association and The Japanese Gastric Cancer Association.
PY - 2018/5/1
Y1 - 2018/5/1
N2 - Background: There have been very few reports of risk score models for the development of gastric cancer. The aim of this study was to develop and validate a risk assessment tool for discerning future gastric cancer risk in Japanese. Methods: A total of 2444 subjects aged 40 years or over were followed up for 14 years from 1988 (derivation cohort), and 3204 subjects of the same age group were followed up for 5 years from 2002 (validation cohort). The weighting (risk score) of each risk factor for predicting future gastric cancer in the risk assessment tool was determined based on the coefficients of a Cox proportional hazards model in the derivation cohort. The goodness of fit of the established risk assessment tool was assessed using the c-statistic and the Hosmer–Lemeshow test in the validation cohort. Results: During the follow-up, gastric cancer developed in 90 subjects in the derivation cohort and 35 subjects in the validation cohort. In the derivation cohort, the risk prediction model for gastric cancer was established using significant risk factors: age, sex, the combination of Helicobacter pylori antibody and pepsinogen status, hemoglobin A1c level, and smoking status. The incidence of gastric cancer increased significantly as the sum of risk scores increased (P trend < 0.001). The risk assessment tool was validated internally and showed good discrimination (c-statistic = 0.76) and calibration (Hosmer–Lemeshow test P = 0.43) in the validation cohort. Conclusions: We developed a risk assessment tool for gastric cancer that provides a useful guide for stratifying an individual’s risk of future gastric cancer.
AB - Background: There have been very few reports of risk score models for the development of gastric cancer. The aim of this study was to develop and validate a risk assessment tool for discerning future gastric cancer risk in Japanese. Methods: A total of 2444 subjects aged 40 years or over were followed up for 14 years from 1988 (derivation cohort), and 3204 subjects of the same age group were followed up for 5 years from 2002 (validation cohort). The weighting (risk score) of each risk factor for predicting future gastric cancer in the risk assessment tool was determined based on the coefficients of a Cox proportional hazards model in the derivation cohort. The goodness of fit of the established risk assessment tool was assessed using the c-statistic and the Hosmer–Lemeshow test in the validation cohort. Results: During the follow-up, gastric cancer developed in 90 subjects in the derivation cohort and 35 subjects in the validation cohort. In the derivation cohort, the risk prediction model for gastric cancer was established using significant risk factors: age, sex, the combination of Helicobacter pylori antibody and pepsinogen status, hemoglobin A1c level, and smoking status. The incidence of gastric cancer increased significantly as the sum of risk scores increased (P trend < 0.001). The risk assessment tool was validated internally and showed good discrimination (c-statistic = 0.76) and calibration (Hosmer–Lemeshow test P = 0.43) in the validation cohort. Conclusions: We developed a risk assessment tool for gastric cancer that provides a useful guide for stratifying an individual’s risk of future gastric cancer.
UR - http://www.scopus.com/inward/record.url?scp=85031498955&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85031498955&partnerID=8YFLogxK
U2 - 10.1007/s10120-017-0768-8
DO - 10.1007/s10120-017-0768-8
M3 - Article
C2 - 29043529
AN - SCOPUS:85031498955
SN - 1436-3291
VL - 21
SP - 383
EP - 390
JO - Gastric Cancer
JF - Gastric Cancer
IS - 3
ER -